Clinical Evaluation Reports Under EU MDR: What They Contain

Clinical Evaluation Reports (CERs) are one of the documents that distributors and institutional buyers most often hear referenced but rarely see in full, because manufacturers generally treat them as confidential technical documentation. Understanding what a CER is meant to contain, however, helps buyers ask better questions during supplier qualification and interpret what a CE mark actually represents.

What a Clinical Evaluation Report Is

A CER is the output document of the clinical evaluation process required under the EU Medical Device Regulation (MDR). It is the manufacturer's structured analysis of the clinical data relevant to a device, used to demonstrate that the device achieves its intended performance and that its benefits outweigh its risks under normal conditions of use. The CER sits inside the technical documentation a Notified Body reviews during conformity assessment, and it is the primary evidence base for the claims made in a device's instructions for use.

The Process Behind the Document

The CER does not stand alone; it summarizes a broader clinical evaluation plan that defines the scope of the device, its intended purpose, the clinical background and the state of the art for similar devices. Manufacturers gather evidence from several possible sources, including the manufacturer's own clinical investigations, published literature on the device or equivalent devices, and post-market clinical follow-up (PMCF) data gathered after a device is already on the market. Where a manufacturer relies on data from an "equivalent" device rather than its own clinical investigation, MDR sets a stricter bar for demonstrating that equivalence than the previous directive did, and this comparison itself is documented within the CER.

Core Contents of a CER

While formatting varies by manufacturer, a CER generally addresses a consistent set of elements:

• Device description and intended purpose, including the clinical claims the manufacturer intends to support.
• State of the art, summarizing current clinical knowledge, alternative treatment options and relevant standards for the device category.
• Appraisal of clinical data, weighing the quality, relevance and weight of each data source identified in the clinical evaluation plan.
• Analysis of benefit-risk, concluding whether the available evidence supports an acceptable benefit-risk profile for the stated intended purpose.
• Residual risks and open questions, including gaps the manufacturer commits to addressing through ongoing PMCF.

This structure is meant to make the manufacturer's reasoning traceable: a reviewer should be able to follow which evidence supports which claim, rather than accepting a conclusion on its face.

Risk Classification and the Depth of Evidence

The depth of clinical evidence expected in a CER scales with device risk classification. A Class III device, such as an implantable or a dermal filler, generally requires a far more substantial clinical investigation and a more detailed CER than a Class I device with a long history of safe use and well-established equivalence to existing products. For higher-risk and novel devices, MDR has also increased Notified Body scrutiny of clinical evaluations, including dedicated clinical evaluation consultation procedures for certain categories. For buyers, this means that asking a supplier how its CER evidence was generated, rather than simply confirming that a CE certificate exists, is a reasonable and informative question during due diligence.

The CER as a Living Document

A CER is not a one-time deliverable filed away after certification. MDR requires it to be updated throughout the device's lifecycle, informed by post-market surveillance and PMCF findings, and reviewed at a frequency proportionate to the device's risk class. A properly maintained CER should reflect real-world performance data accumulated after launch, not only the evidence available at the time of initial certification. A manufacturer that cannot describe how its CER is kept current is signaling a gap in its broader post-market quality system, which is relevant to any distributor relying on that manufacturer's regulatory standing.

The Takeaway

A Clinical Evaluation Report is the documented link between the clinical evidence a manufacturer holds and the claims that appear in a device's labeling and instructions for use. For distributors and institutional buyers, understanding the general structure of a CER, and the fact that it is a living document rather than a historical artifact, supports more informed supplier qualification conversations and a clearer picture of what sits behind a CE mark.

This is general educational information, not legal or regulatory advice; consult the current official texts and your competent authority.